News Overview

Promoter/Promoter Group of Lumax Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

In terms of SEBI Circular No. SEBI/HO/CFD/CMDI/CIR/9/2019/140 dated November 21, 2019; we are enclosing herewith relevant disclosures of defaults for the quarter and year ended on March 31, 2022. You are requested to take the above submissions in your records.

Promoter/Promoter Group of Sastasundar Ventures Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Sundaram Clayton Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

NLC India Limited has informed the Exchange about press release dated 06-Apr-2022 titled 29.20 Billion Units of Power generated during FY 2021-22 - 18.64% higher than previous year.

Promoter/Promoter Group of Tarmat Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 31-Mar-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg.

Promoter/Promoter Group of R. S. Software (India) Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Ruchi Soya Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Star Cement Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022